Ergebnis der Suchanfrage nach Therapie

ARTTIC Innovation GmbH

Event Announcement: VIROFIGHT Hybrid Symposium

Fördergesellschaft IZB mbH

2

Record financing rounds at the Munich biotech hub

ARTTIC Innovation GmbH

canSERV relaunches Open Call for Service Provision

STADA Arzneimittel AG

Press release: STADA continues strong growth journey in the first half of 2024

ARTTIC Innovation GmbH

canSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open

STADA Arzneimittel AG

Press release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo

STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK

Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...

ARTTIC Innovation GmbH

3

canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research

Deutsche Post DHL Group

2

PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador

STADA Arzneimittel AG

Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...

STADA Arzneimittel AG

Press release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

OPTIMA packaging group GmbH

5

Reflecting on a successful Pharma Forum 2023

STADA Arzneimittel AG

2

Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals

STADA Arzneimittel AG

2

Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty

STADA Arzneimittel AG

Press release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe

Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...

Fördergesellschaft IZB mbH

2

The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics

Fördergesellschaft IZB mbH

2

COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant

Fördergesellschaft IZB mbH

7

Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Fördergesellschaft IZB mbH

2

A higher omega-3 level apparently protects from dying from COVID-19

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

Fördergesellschaft IZB mbH

KOPIE VON: Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Enclosed we send you the news of the day about the IZB. We would be pleased if you would consider the message in your news coverage. If you have any question ...

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB

Fördergesellschaft IZB mbH

High investor density at the Pitch Day hosted by IZB